V-Wave has developed a miniature valve, which is implanted by catheterization into the left ventricle of the heart, to reduce the pressure on the muscle by controlling the blood flow between the heart chambers in patients who are frequently hospitalized with heart attacks.

Medical Device
Private
Visit Website
Additional Portfolio Companies
Abcuro
Adicet Bio
AgomAb Therapeutics
Allena Pharmaceuticals
ArQule
Cathworks
cCAM Biotherapeutics
CheckCap
CytoReason
Dynacure
Eloxx Pharmaceuticals
Enlivex Therapeutics
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Genocea
Horama
IMEL Biotherapeutics
Immunic Therapeutics
Kamari Pharma
Keros Therapeutics
Kite Pharma
Levation Pharma
LogicBio Therapeutics
Lutris Pharma
Mereo BioPharma
Metabomed
NovellusDX
Ocon Medical
Opiant
PACT Pharma
Pi Therapeutics
Prevail Therapeutics
Precirix (Formerly Camel-IDS)
ProQR
Protalix
Raziel Therapeutics
ReWalk
Saniona
SilverBack Therapeutics
Soligenix
Stargazer Pharmaceuticals
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
Vascular Graft Solutions
UroGen
V-Wave
July 12, 2015